Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
Ulrich Pecks, Head of Obstetrics and Maternal Health and Fetal Development at University Hospital Würzburg, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“In addition to our recent publication on VTE prophylaxis after CS in JPM we are proud of our accepted review in Archives which provides an overview of guidelines for hereditary thrombophilia in pregnancy.
Key points:
- Pregnant women with inherited thrombophilia have a significantly higher risk of venous thromboembolism (VTE), up to approximately 40-fold depending on type and history.
Risk classification:
- Low risk: e.g., heterozygous factor V Leiden or prothrombin mutation
- High risk: e.g., homozygous mutations, combined thrombophilia, severe antithrombin/protein C/S deficiency
Guidelines vary:
International recommendations for thromboprophylaxis differ widely – no universal standard.
Use of prophylaxis (heparin):
Generally recommended for high-risk thrombophilia (during pregnancy and 6 weeks postpartum).
For low-risk, only if additional risk factors or positive family history are present.
Limited evidence:
There is no strong evidence from randomized controlled trials proving that pharmacological prophylaxis significantly reduces VTE risk.
Risk–benefit balance:
Prophylaxis carries risks (e.g., bleeding), and VTE risk may be overestimated – possible overtreatment.
Individualized decision-making:
Management should be case-by-case, considering individual risk profile, history, and patient preference.
Bottom line:
Although VTE risk is increased in pregnant women with thrombophilia, inconsistent guidelines and limited evidence mean that prophylaxis decisions must be individualized.”
Title: Recommendations from guidelines for the prevention of venous thromboembolism in pregnant women with inherited thrombophilia
Authors: Werner Rath, Panagiotis Tsikouras, Ulrich Pecks
Read the Full Article on Archives of Gynecology and Obstetrics.

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 14, 2026, 17:24EHC ERIN Webinar on Fibrinogen Disorders
-
Oct 14, 2026, 16:50Peter Kouides: The Role of Multidisciplinary Networks in Women’s Hematologic Care
-
Oct 14, 2026, 16:35Thaís Leonel: Analytical Consistency as a Foundation for Evidence-Based Thrombosis Management
-
Oct 14, 2026, 16:28Christina Yiangou: Presenting the HemaFAIR Project at ASCAT 2026 in London
-
Oct 14, 2026, 16:27ITP Research and the Importance of Patient Involvement – ITP Australia and New Zealand
-
Oct 14, 2026, 16:19Ganesh Mohan: Complexities of Thrombosis Care Across Diverse Patient Populations
-
Oct 14, 2026, 16:17Louise St. Germain Bannon: Every Conversation Matters Beyond World Thrombosis Day
-
Oct 14, 2026, 16:11Christina Pierre: A Life-Course Approach to Thrombosis Risk in Women
-
Oct 14, 2026, 16:06Belinda Minnaar: Recognizing Leadership in VTE Prevention on World Thrombosis Day